Results 251 to 260 of about 94,256 (324)

Prevalence of erectile dysfunction as long-COVID symptom in hospitalized Japanese patients. [PDF]

Sci Rep
Kato H, Ichihara N, Saito H, Fujitani S, Ota K, Takahashi Y, Harada T, Hattori T, Komeya M, Hosozawa M, Muto Y, Hori M, Iba A, Iso H, Iso H, COVID-19 Recovery Study II Group.   +15 more
europepmc   +1 more source

Intracavernous Calcitonin-gene Related Peptide Plus Prostaglandin E 1. Possible Alternative to Penile Implants in Selected Patients. [PDF]

, 1994
Becker, Armin J., Djamilian, Mohamad H., Jonas, Udo, Kuczyk, M., Stief, Christian Georg, Thon, Walter F., Truss, Michael C.   +6 more
core   +1 more source

Preoperative Pyuria as a Predictor of False‐Positive Rates in the Photodynamic Diagnosis of Nonmuscle‐Invasive Bladder Cancer Using Oral 5‐Aminolevulinic Acid

International Journal of Urology, EarlyView.
ABSTRACT Objectives Although photodynamic diagnosis (PDD) using 5‐aminolevulinic acid (ALA) is a highly a sensitive and excellent method for detecting nonmuscle‐invasive bladder cancer, false‐positive rates should not be overlooked. One of the factors causing false‐positive results is inflammation.
Shinkuro Yamamoto, Hideo Fukuhara, Hajime Kuroiwa, Ryu Shigehisa, Hiroto Osakabe, Tomoya Nao, Tsutomu Shimamoto, Nobutaka Shimizu, Satoshi Fukata, Shingo Ashida, Takashi Karashima, Keiji Inoue   +11 more
wiley   +1 more source

Comparative Analysis of Local Versus General Anesthesia and Its Impact on Erectile Dysfunction Risk Following Penile Surgery. [PDF]

Cureus
Harris M, Taylor S, McMillan E, Zinabu SW, Wheaton N, Monroe D, Kim S, Ocampo E, Ogbutor K, Michael MB.   +9 more
europepmc   +1 more source

Impact of Estimated Glomerular Filtration Rate and Serum C‐Reactive Protein Level to Overall Survival After Second‐Line Targeted Therapy Following Immuno‐Oncology Combination Therapy for Advanced Renal Cell Carcinoma

International Journal of Urology, EarlyView.
ABSTRACT Objectives Immune checkpoint inhibitor (ICI)‐based combination therapies are first‐line treatments for locally advanced or metastatic renal cell carcinoma (mRCC). However, second‐line treatment efficacy remains uncertain due to limited large randomized trials. This study evaluated real‐world oncological outcomes after second‐line treatments in
Keita Nakane, Hiromitsu Watanabe, Taku Naiki, Kiyoshi Takahara, Teruo Inamoto, Takahiro Yasui, Ryoichi Shiroki, Hideaki Miyake, Takuya Koie   +8 more
wiley   +1 more source

Addressing unmet needs for patients with erectile dysfunction: a narrative review of topical therapies. [PDF]

Sex Med
Brock GB, Hellstrom WJG, Giraldi A, Honig S.   +3 more
europepmc   +1 more source

Advances in stem cell therapy for erectile dysfunction: preclinical evidence and emerging therapeutic approaches. [PDF]

Front Med (Lausanne)
Fu X, Sheikholeslami A, Zhanbyrbekuly U, Davoodi Asl F, Mussin NM, Fazaeli H, Daniyalov K, Tanideh N, Mahdipour M, Kurmanalina MA, Tamadon A.   +10 more
europepmc   +1 more source

Editorial Comment on “Is Docetaxel Essential for Darolutamide‐Based Metastatic Hormone‐Sensitive Prostate Cancer Therapy?”

International Journal of Urology, EarlyView.
Koji Hatano
wiley   +1 more source

Current Evidences and Future Perspectives in the Management of Metastatic Non‐Clear Cell Renal Cell Carcinoma

International Journal of Urology, EarlyView.
ABSTRACT Renal cell carcinoma is a heterogeneous disease with diverse phenotypes. Renal cell carcinoma classification is based on morphological and molecular characteristics and falls into 2 main categories: clear cell renal cell carcinoma and non‐clear cell renal cell carcinoma.
Shotaro Nakanishi, Junichi Inokuchi
wiley   +1 more source

The Relationship Between Femoral Head Avascular Necrosis and Erectile Dysfunction: A Retrospective Case-Control Study Conducted in Türkiye. [PDF]

J Clin Med
Özdemir E, Özdeş AA, Topsakal FE, Altay N, Özdeş HU, Demirel E.   +5 more
europepmc   +1 more source